Correlation Between Longboard Pharmaceuticals and Pulmatrix

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Longboard Pharmaceuticals and Pulmatrix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Longboard Pharmaceuticals and Pulmatrix into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Longboard Pharmaceuticals and Pulmatrix, you can compare the effects of market volatilities on Longboard Pharmaceuticals and Pulmatrix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Longboard Pharmaceuticals with a short position of Pulmatrix. Check out your portfolio center. Please also check ongoing floating volatility patterns of Longboard Pharmaceuticals and Pulmatrix.

Diversification Opportunities for Longboard Pharmaceuticals and Pulmatrix

0.45
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Longboard and Pulmatrix is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Longboard Pharmaceuticals and Pulmatrix in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pulmatrix and Longboard Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Longboard Pharmaceuticals are associated (or correlated) with Pulmatrix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pulmatrix has no effect on the direction of Longboard Pharmaceuticals i.e., Longboard Pharmaceuticals and Pulmatrix go up and down completely randomly.

Pair Corralation between Longboard Pharmaceuticals and Pulmatrix

Given the investment horizon of 90 days Longboard Pharmaceuticals is expected to generate 3.01 times more return on investment than Pulmatrix. However, Longboard Pharmaceuticals is 3.01 times more volatile than Pulmatrix. It trades about 0.07 of its potential returns per unit of risk. Pulmatrix is currently generating about 0.07 per unit of risk. If you would invest  745.00  in Longboard Pharmaceuticals on September 1, 2024 and sell it today you would earn a total of  5,253  from holding Longboard Pharmaceuticals or generate 705.1% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Longboard Pharmaceuticals  vs.  Pulmatrix

 Performance 
       Timeline  
Longboard Pharmaceuticals 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Longboard Pharmaceuticals are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite fairly unfluctuating basic indicators, Longboard Pharmaceuticals demonstrated solid returns over the last few months and may actually be approaching a breakup point.
Pulmatrix 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Pulmatrix are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of very weak essential indicators, Pulmatrix displayed solid returns over the last few months and may actually be approaching a breakup point.

Longboard Pharmaceuticals and Pulmatrix Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Longboard Pharmaceuticals and Pulmatrix

The main advantage of trading using opposite Longboard Pharmaceuticals and Pulmatrix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Longboard Pharmaceuticals position performs unexpectedly, Pulmatrix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pulmatrix will offset losses from the drop in Pulmatrix's long position.
The idea behind Longboard Pharmaceuticals and Pulmatrix pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Complementary Tools

Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world